RNU6-118P

Across TCGA pan-cancer cohorts, RNU6-118P RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated RNU6-118P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-118P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-118P expression acts as an unfavorable survival marker, although some lineages such as UCS and STAD show a favorable association.

KIRC, ACC, and UCS are the cancer types where RNU6-118P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.526	0.719	<.001	92	view →
ACC	OS	Median	All	0.396	0.792	<.001	72	view →
UCS	OS	Tertile	III,IV	0.681	0.348	.003	70	view →
MESO	OS	Tertile	All	0.278	0.521	.001	61	view →
STAD	DFS	Quartile	III,IV	0.695	0.250	.003	56	view →
BLCA	OS	Quartile	III,IV	0.780	0.587	.011	23	view →
LAML	DFS	Median	All	0.563	0.228	.005	20	view →
KIRP	DFS	Quartile	II,III,IV	0.191	0.816	.015	10	view →
UVM	DFS	Quartile	All	0.311	0.853	.034	8	view →
SKCM	OS	Quartile	III,IV	0.554	0.270	.010	8	view →
READ	DFS	Tertile	II,III,IV	0.960	0.662	.009	7	view →
THCA	OS	Median	All	1.000	0.985	.014	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

RNU6-118P–KIRC (OS)

Open the KIRC breakdown →